Clinical Trial Update: Safety Study of CTS21166 to Treat Alzheimer Disease [Phase 1]

View source ↗

Summary

The document reports the completion of a Phase 1 safety study evaluating CTS21166 for Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• CTS21166

Snippet

Sponsor: CoMentis | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED